Viatris Inc.

VTRS

Healthcare|Drug Manufacturers - Specialty & Generic|US

$19.91

+0.94 (+4.96%)

DCF Value

$19.78

Cash / Share

$1.65

Clinical Trials (501)

Trial	Conditions	Phase	Status	Enrollment	Design	Drug
NCT06875258 PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)	Erectile Dysfunction Following Radical Prostatectomy	P4	Recruiting	198	RCT, Open-label	Sildenafil
NCT07606625 Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment	Dry Eye, Meibomian Gland Dysfunction	P4	Recruiting	65	Open-label	Varenicline 0.03Mg/Spray Nasal Soln
NCT07816835 Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD	COPD (Chronic Obstructive Pulmonary Disease), Chronic Obstructive Pulmonary Disease (COPD)	P4	Recruiting	120	RCT, Single-blind	—
NCT05648500 A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus	Lupus Erythematosus, Systemic	P3	Active	470	RCT, Double-blind	Cenerimod, Placebo
NCT07486024 Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)	MDR-TB, Tuberculosis Multi Drug Resistant Active	P3	Recruiting	55	RCT, Open-label	Bedaquiline Oral Tablet, Bedaquiline Oral Tablet
NCT07201129 A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment	Nephritis, Lupus, Lupus Erythematosus, Systemic	P3	Recruiting	300	RCT, Double-blind	Cenerimod, Placebo
NCT05672576 A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus	Lupus Erythematosus, Systemic	P3	Active	451	RCT, Double-blind	Cenerimod, Placebo
NCT06672016 Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential	Female Contraception	P3	Active	1,630	Open-label	Transdermal system containing progestin
NCT07365904 Investigating Ovulation Inhibition for Use as a Contraceptive	Contraception	P2	Recruiting	60	RCT, Open-label	MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN)
NCT07266090 A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)	SLE - Systemic Lupus Erythematosus	P2	Active	15	Open-label	cenerimod 4 mg
NCT07923045 A Phase 1/2, Single-Dose, Multicenter, Dose Escalation, Clinical Trial to Evaluate the Safety and Efficacy of MR-146: An Open-Label Part 1 in Participants With Stage 1 or 2 Neurotrophic Keratopathy and a Double-Masked Part 2 in Participants With Stage 2 Neurotrophic Keratopathy	Neurotrophic Keratopathy	P1P2	Recruiting	18	Open-label	—
NCT07231796 Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience	Cancer, Opioid Induced Constipation (OIC)		Recruiting	100	—	Naldemedine, an peripherally acting opioid antagonist
NCT06052995 Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.	Mild to Moderate Atopic Dermatitis		Active	130	—	Elidel 1% Topical Cream
NCT06135324 Impairments That Affect Correct Inhaler Use in COPD	COPD		Active	500	—	—
NCT03502070 Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules	Cystic Fibrosis	P4	Completed	47	Open-label	Placebo
NCT01190007 Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients	Hypertension, Hypercholesterolemia	P4	Completed	159	Open-label	Caduet
NCT00297973 Cardiovascular Risk Assessment in Patients Treated With Caduet	Hypertension	P4	Completed	1,442	RCT, Open-label	—
NCT04652245 Dymista Allergen Chamber - Onset of Action Study	Seasonal Allergic Rhinitis	P4	Completed	216	RCT, Double-blind	Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 3, Treatment B (Placebo): Nasal spray with no active dose (Dymista vehicle) at Visit 5, Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 5, Treatment B (Placebo): Nasal spray with no active dose (Dymista vehicle) at Visit 3
NCT05319756 Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users	Abuse Potential	P4	Completed	54	RCT, Double-blind	gabapentin 600 mg, gabapentin 1200 mg, gabapentin 600 mg and oxycodone HCl 20 mg, gabapentin 1200 mg and oxycodone HCl 20 mg, oxycodone HCl 20 mg, placebo
NCT00442325 Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets	Coronary Arteriosclerosis, Diabetes Mellitus, Type 2	P4	Completed	595	Open-label	Atorvastatin (Lipitor)
NCT02060487 Effects of Oral Sildenafil on Mortality in Adults With PAH	Pulmonary Arterial Hypertension	P4	Terminated	385	RCT, Double-blind	sildenafil citrate, sildenafil citrate, sildenafil citrate
NCT00174395 A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine	Migraine	P4	Completed	220	RCT, Open-label	eletriptan
NCT00644800 A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis	Schizophrenia, Mania	P4	Completed	89	Open-label	Ziprasidone
NCT00381095 A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer	Bone Neoplasms, Pain, Intractable	P4	Terminated	152	RCT, Double-blind	Pregabalin, Placebo
NCT07777965 Abuse Potential of Oral Gabapentin in Healthy, Non-Drug-Dependent Individuals With Recreational Sedative Drug Use Experience	Healthy Non-dependent, Recreational Sedative Users	P4	Completed	44	RCT, Double-blind	Alprazolam (Xanax), Placebo, Gabapentin (Neurontin® (Registered Trademark)), Gabapentin (Neurontin® (Registered Trademark))
NCT00139776 Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"	Osteoarthritis, Knee, Osteoarthritis, Hip	P4	Completed	875	RCT, Double-blind	Celecoxib, Celecoxib
NCT00323297 Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension	P4	Completed	105	RCT, Double-blind	Bosentan, Bosentan, Sildenafil Citrate
NCT00645320 A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study	Pyschotic Disorders	P4	Completed	75	Open-label	Ziprasidone
NCT00728988 Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome	Acute Coronary Syndrome	P4	Completed	499	RCT, Open-label	Atorvastatin, Atorvastatin
NCT00646841 Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients	Hypertension	P4	Completed	89	Open-label	Doxazosin gastrointestinal therapeutic system (GITS)
NCT00640627 Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen	Osteoarthritis, Knee	P4	Completed	380	RCT, Double-blind	Celecoxib, Placebo
NCT00143195 Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina	Myocardial Ischemia	P4	Completed	200	RCT, Open-label	Amlodipine, iso- 5 - mononitrate
NCT00143377 Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB	Urinary Incontinence	P4	Completed	600	RCT, Double-blind	tolterodine SR, overactive bladder
NCT00408473 Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.	Atrial Fibrillation	P4	Terminated	256	RCT, Double-blind	Flecainide
NCT00147654 Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction	Urinary Incontinence	P4	Completed	830	RCT, Double-blind	Tolterodine ER 4 mg QD, Tamsulosin 0.4 mg QD
NCT00159679 Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy	Diabetic Neuropathy, Painful	P4	Completed	167	RCT, Double-blind	Pregabalin
NCT00137397 A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder	Urinary Incontinence	P4	Completed	80	RCT, Double-blind	Tolterodine ER, Placebo
NCT00359151 Celebrex Total Knee Arthroplasty Study	Osteoarthritis, Pain	P4	Terminated	22	RCT, Double-blind	Celecoxib, Placebo
NCT00245596 Evaluation of the Index of Sexual Life Questionnaire	Impotence	P4	Completed	120	Open-label	sildenafil
NCT00994461 Study Of Celecoxib In Healthy Subjects	Healthy Volunteers	P4	Completed	190	RCT, Double-blind	Celecoxib, Loxoprofen, Placebo
NCT00634985 Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs	Migraine	P4	Completed	120	Open-label	eletriptan
NCT01176968 Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction	Myocardial Infarction	P4	Completed	1,012	RCT, Double-blind	Eplerenone, Placebo
NCT00855738 A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice	Focal Epilepsy	P4	Completed	111	Open-label	Gabapentin, Lamotrigine, Levetiracetam, Pregabalin, Oxcarbacepine, Tiagabine, Topiramate, Zonisamide
NCT00407537 Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors	Hypertension, Hypercholesterolemia	P4	Completed	1,531	RCT, Open-label	Amlodipine besylate/atorvastatin calcium single pill combination
NCT00807846 A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects	Arthritis, Juvenile Rheumatoid	P4	Completed	201	RCT, Double-blind	Celecoxib, Naproxen
NCT00082589 The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure	Heart Failure, Congestive	P4	Completed	250	RCT, Double-blind	Eplerenone
NCT00645268 A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes	Erectile Dysfunction, Diabetes Mellitus, Type 2	P4	Completed	300	RCT, Double-blind	sildenafil, placebo, sildenafil
NCT00230789 Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.	Urinary Incontinence	P4	Completed	417	Open-label	Tolterodine ER 4 mg QD
NCT00708370 A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.	Dyslipidemia	P4	Completed	297	RCT, Open-label	—
NCT00301262 Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied	Impotence	P4	Completed	183	RCT, Double-blind	Viagra (Sildenafil citrate)
NCT00430716 To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.	Pulmonary Arterial Hypertension	P4	Terminated	130	RCT, Double-blind	Sildenafil citrate, Sildenafil citrate, Sildenafil citrate, Sildenafil citrate
NCT01298466 Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study	Low Back Pain, Neuralgia	P4	Withdrawn	—	Open-label	Pregabalin
NCT00159757 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients	Schizophrenia	P4	Terminated	150	Open-label	ziprazidone
NCT00644956 A Randomized, Open-Label, Crossover, Multicenter, Single Dose Comparator Study Evaluating Onset Of Penile Rigidity In Men With Erectile Dysfunction Who Are Treated With Sildenafil And Tadalafil	Erectile Dysfunction	P4	Completed	56	RCT, Open-label	tadalafil, sildenafil
NCT00644631 A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled, Flexible Dose Escalation Study To Evaluate Sexual And Relationship Satisfaction In The Female Partner Of Men With Erectile Dysfunction Treated With Sildenafil Citrate	Erectile Dysfunction	P4	Completed	300	RCT, Double-blind	sildenafil, placebo
NCT00249730 Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.	Impotence	P4	Completed	510	RCT, Double-blind	Sildenafil
NCT00654017 A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving Hemodialysis	Erectile Disfunction, Hemodialysis	P4	Completed	100	RCT, Double-blind	placebo, sildenafil
NCT00245258 Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction	Impotence	P4	Completed	312	RCT, Double-blind	Sildenafil Citrate
NCT00894790 Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident	Pain	P4	Terminated	8	RCT, Open-label	Celecoxib, oral Diclofenac
NCT00648323 Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement	Prostate	P4	Completed	80	Open-label	Doxazosin mysylate GITS
NCT00631696 Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo	Healthy	P4	Completed	222	RCT, Double-blind	Pregabalin, Placebo
NCT00159718 Double Blind Atorvastatin Amlodipine Study	Angina	P4	Completed	360	RCT, Double-blind	amlodipine, atorvastatin
NCT00634166 Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group	Burns	P4	Terminated	220	Open-label	Sulfamylon® For 5 % Topical Solution, Topical Antimicrobial/Antifungal Medications
NCT00163150 Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke	Cerebrovascular Accident, Hypercholesterolemia	P4	Completed	128	RCT, Double-blind	Atorvastatin
NCT00647101 A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma	Glaucoma, Open-Angle, Ocular Hypertension	P4	Completed	600	Open-label	Latanoprost
NCT00629681 A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia	Painful Diabetic Neuropathy and Post Herpetic Neuralgia	P4	Completed	217	Open-label	Pregabalin
NCT00282932 Detrol LA In Men With Overactive Bladder.	Overactive Bladder (OAB)	P4	Completed	600	RCT, Double-blind	Detrol LA
NCT00159900 Quality of Erection Study	Erectile Dysfunction	P4	Completed	300	RCT, Double-blind	Sildenafil Citrate
NCT00159692 Amlodipine Diabetic Hypertension Efficacy Response Trial	Hypertension	P4	Completed	739	RCT, Double-blind	Amlodipine
NCT01020526 Pregabalin In Adolescent Patients With Fibromyalgia	Fibromyalgia	P4	Completed	63	Open-label	pregabalin
NCT00159666 Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia	Post-Herpetic Neuralgia	P4	Completed	255	RCT, Double-blind	pregabalin
NCT00143260 Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose	Impotence	P4	Completed	250	RCT, Double-blind	Viagra (Sildenafil Citrate) 100 mg
NCT00351611 Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo	Epilepsies, Partial	P4	Completed	187	RCT, Double-blind	Lyrica (pregabalin), placebo
NCT01455428 Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)	Postherpetic Neuralgia ( PHN )	P4	Completed	223	RCT, Double-blind	Lyrica (pregabalin), Placebo
NCT00174330 Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia	Hypertension, Hyperlipidemia	P4	Completed	330	RCT, Open-label	atorvastatin, amlodipine
NCT01322867 A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets	Healthy	P4	Completed	30	RCT, Open-label	alprazolam tablet, alprazolam oral solution
NCT00640549 Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus	Hyperlipidemia, Diabetes Mellitus, Type 2	P4	Terminated	41	RCT, Double-blind	Atorvastatin, Placebo
NCT00634348 A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients	Schizophrenia	P4	Completed	256	RCT, Double-blind	Aripiprazole, Ziprasidone
NCT00346216 Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen	Arthritis, Rheumatoid	P4	Completed	24,081	RCT, Double-blind	celecoxib, Ibuprofen, Naproxen
NCT00156078 A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)	Diabetic Neuropathy, Painful	P4	Completed	450	RCT, Double-blind	pregabalin
NCT00239109 Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.	Schizophrenia	P4	Completed	112	RCT, Double-blind	Ziprasidone, Olanzapine
NCT00635531 A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder	Panic Disorder	P4	Terminated	16	RCT, Double-blind	alprazolam XR
NCT00677352 A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder	Panic Disorder	P4	Completed	321	RCT, Double-blind	sertraline, Paroxetine
NCT00624780 Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder	Generalized Anxiety Disorder	P4	Completed	615	RCT, Double-blind	Pregabalin, Lorazepam, Pregabalin, Placebo
NCT00406315 Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone	Schizophrenia, Schizoaffective Disorder	P4	Completed	255	Open-label	ziprasidone
NCT00917644 Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet	Hypercholesterolemia	P4	Completed	76	RCT, Open-label	Atorvastatin
NCT00446797 Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain	Ankle Sprain	P4	Completed	278	RCT, Open-label	Non-selective NSAIDS, Celecoxib
NCT00644982 A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression	Depressive Disorder, Major	P4	Completed	163	RCT, Double-blind	sertraline, venlafaxine XR
NCT00647543 Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand	Dyslipidemias	P4	Completed	242	Open-label	Atorvastatin, Atorvastatin, Atorvastatin
NCT01642407 Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension, Hypertension, Pulmonary	P4	Completed	6	Open-label	Sildenafil
NCT01727791 A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women	Healthy Lactating Women	P4	Completed	10	Open-label	pregabalin (Lyrica)
NCT00645151 A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol	Dyslipidemias	P4	Completed	512	Open-label	Atorvastatin, Atorvastatin, Atorvastatin
NCT00189293 Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts	Genital Warts	P4	Completed	128	RCT, Double-blind	Imiquimod
NCT00411437 Effects Of Detrol LA On Memory And Cognition In Elderly Population	Memory, Cognition	P4	Completed	220	RCT, Double-blind	Tolterodine ER, Oxybutynin ER
NCT00640432 Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain	Low Back Pain	P4	Completed	244	RCT, Double-blind	Diclofenac, Celecoxib
NCT00468650 A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction.	Erectile Dysfunction	P4	Completed	117	Open-label	sildenafil citrate
NCT01302938 Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder	Overactive Bladder	P4	Terminated	18	RCT, Double-blind	Tolterodine ER, Placebo
NCT00644748 A Study on the Efficacy and Safety of Gabapentin in the Treatment of Patients With Painful Diabetic Neuropathy	Diabetic Neuropathies	P4	Completed	95	Open-label	gabapentin
NCT00373685 GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)	Osteoarthritis	P4	Completed	8,067	RCT, Open-label	Celecoxib, Any commercially available NSAID with the indication for osteoarthritis
NCT00140049 A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma	Glaucoma, Open Angle, Ocular Hypertension	P4	Completed	238	RCT, Single-blind	Xalacom, Cosopt
NCT00151463 QEQ Treatment Responsiveness Evaluation Study	Impotence	P4	Completed	100	Open-label	sildenafil citrate
NCT04570436 Evaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience	Abuse Potential	P4	Completed	52	RCT, Double-blind	gabapentin 600 mg, gabapentin 1200 mg, gabapentin 1800 mg, diazepam 20 mg
NCT00143481 Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women	Urinary Incontinence	P4	Completed	400	RCT, Double-blind	Tolterodine ER 4mg QD
NCT00174304 Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.	Hypertension, Hyperlipidemia	P4	Completed	1,120	RCT, Open-label	Amlodipine/atorvastatin single pill
NCT00540293 Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study	Dyslipidemias	P4	Completed	425	Open-label	Atorvastatin
NCT00407797 Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial	Partial Seizures	P4	Terminated	136	Open-label	Pregabalin
NCT00141427 Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.	Seizures	P4	Completed	540	Open-label	Pregabalin
NCT00777127 Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses	Actinic Keratosis	P4	Completed	258	RCT, Open-label	Imiquimod, Diclofenac
NCT00380874 Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer	Chemotherapy-Induced Peripheral Neuropathy	P4	Terminated	64	RCT, Double-blind	Pregabalin, Placebo
NCT07597473 Dymista in Chinese Adolescents	Allergic Rhinitis Due to Allergens	P4	Completed	100	Open-label	Treatment with 137 µg azelastine hydrochloride and 50 μg of fluticasone propionate
NCT01453179 Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)	Actinic Keratosis	P4	Completed	221	RCT, Open-label	Imiquimod, Diclofenac
NCT00638807 Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen	Osteoarthritis, Knee	P4	Completed	388	RCT, Double-blind	Celecoxib
NCT00654082 A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction	Spinal Cord Injury, Erectile Dysfunction	P4	Completed	88	RCT, Double-blind	sildenafil, placebo
NCT00632385 Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy	Migraine	P4	Completed	127	Open-label	Eletriptan
NCT00143221 Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH)	Impotence	P4	Completed	350	RCT, Double-blind	Viagra, Placebo
NCT00640809 Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole	Bowel Diseases, Inflammatory	P4	Completed	408	RCT, Double-blind	Celecoxib, Ibuprofen plus Omeprazole
NCT00648596 A Study to Evaluate Self-esteem and Relationships in Males With Erectile Dysfuntion	Erectile Dysfunction	P4	Completed	780	RCT, Double-blind	sildenafil, placebo
NCT00666796 A Study to Assess the Pharmacodynamic Interaction Between Gabapentin and Ethanol in Healthy Subjects	Insomnia	P4	Completed	20	RCT, Double-blind	Placebo ethanol, Ethanol, Placebo, Gabapentin, Ethanol, Placebo, Gabapentin, Placebo ethanol
NCT00412113 A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk	Dyslipidemia, Hypertension	P4	Completed	245	RCT, Double-blind	Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill combination, Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill combination
NCT00159809 Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction	Impotence, Depression	P4	Completed	140	RCT, Double-blind	Viagra (Sildenafil citrate)
NCT00634790 A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks	Panic Disorder	P4	Terminated	49	Open-label	alprazolam XR
NCT00163202 Comparative Atorvastatin Pleiotropic Effects	Coronary Arteriosclerosis, Hypercholesterolemia	P4	Completed	330	RCT, Double-blind	Atorvastatin
NCT00137072 Mild To Moderate Erectile Dysfunction Study	Impotence	P4	Completed	355	RCT, Double-blind	Viagra (Sildenafil Citrate) 100 mg
NCT05165485 Phase 4 COPD and Suboptimal Inspiratory Flow Rate	Chronic Obstructive Pulmonary Disease	P4	Completed	404	RCT, Double-blind	Revefenacin, Tiotropium, Revefenacin Placebo, Tiotropium Placebo
NCT03004131 MP-AzeFlu Allergen Chamber - Onset of Action Study	Seasonal Allergic Rhinitis	P4	Completed	82	RCT, Double-blind	Azelastine hydrochloride + fluticasone propionate nasal spray, Placebos, fluticasone propionate nasal spray + loratadine
NCT06367998 Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair	Rotator Cuff Tears, Central Sensitisation	P4	Unknown	76	RCT, Open-label	Pregabalin
NCT00139724 Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet	Urinary Incontinence	P3	Completed	260	RCT, Double-blind	tolterodine extended release capsule
NCT04674800 Extension Study of MYL-1701P-3001 for Safety and Efficacy	Diabetic Macular Edema	P3	Completed	52	Open-label	MYL-1701P, a proposed biosimilar to Eylea
NCT01113541 One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome	Bipolar Disorder	P3	Terminated	13	Open-label	Ziprasidone HCL (oral)
NCT00596466 Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures	Epilepsy	P3	Completed	75	Open-label	pregabalin
NCT00905437 Study To Investigate The Effectiveness Of Pregabalin For Management Of Patients Undergoing Total Hip Replacement	Pain, Perioperative	P3	Terminated	72	RCT, Double-blind	Placebo, Pregabalin
NCT00800267 A Study of Glaucoma or Ocular Hypertension in Patients Within the United States	Ocular Hypertension, Glaucoma	P3	Completed	418	RCT, Double-blind	latanoprost 0.005%, fixed combination latanoprost-timolol, timolol 0.5%
NCT00716859 A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.	Glaucoma	P3	Completed	139	RCT, Double-blind	Timolol, latanoprost
NCT00383019 A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).	Glaucoma, Ocular Hypertension	P3	Completed	300	RCT, Double-blind	Xalatan, Xalacom
NCT01270828 Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia	Post Herpetic Neuralgia	P3	Completed	806	RCT, Double-blind	Pregabalin, placebo
NCT00151450 Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder	Anxiety	P3	Completed	390	RCT, Double-blind	Pregabalin, Venlafaxine XR
NCT00143130 Pregabalin In Partial Seizures Extension Study	Seizures	P3	Completed	227	Open-label	Pregabalin
NCT00159887 Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension	Pulmonary Hypertension	P3	Completed	260	Open-label	Sildenafil citrate
NCT03599791 DYmista NAsal Spray in CHInese Patients	Allergic Rhinitis	P3	Completed	900	RCT, Double-blind	Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT, Azelastine Hydrochloride 0.137 MG/ACTUAT, Fluticasone Propionate 0.05 MG/ACTUAT
NCT00806026 Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients	Idiopathic Restless Legs Syndrome	P3	Completed	731	RCT, Double-blind	placebo and pregabalin, pramipexol, pramipexol, Pregabalin, pramipexol, pramipexol
NCT00150306 A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD	Stress Disorders, Post-Traumatic	P3	Terminated	160	RCT, Double-blind	Zoloft (Sertraline)
NCT00666770 A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance	Transient Insomnia	P3	Completed	309	RCT, Double-blind	Gabapentin, Gabapentin, Placebo
NCT03760068 Mylan Insulin Aspart Study	Diabetes Mellitus, Type 1	P3	Completed	478	RCT, Open-label	MYL-1601D Product, FlexPen NovoLog®
NCT02472964 Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.	Breast Cancer	P3	Completed	500	RCT, Double-blind	Trastuzumab, MYL- 1401O, Paclitaxel, Docetaxel
NCT00415623 A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient	Hypertension	P3	Completed	305	RCT, Double-blind	Amlodipine, Amlodipine
NCT01202227 An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain	Spinal Cord Diseases, Spinal Cord Injuries	P3	Completed	104	Open-label	pregabalin
NCT04957719 Selatogrel Outcome Study in Suspected Acute Myocardial Infarction	Acute Myocardial Infarction	P3	By Invite	25,000	RCT, Double-blind	—
NCT00143156 Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy	Diabetic Neuropathies	P3	Completed	450	RCT, Double-blind	pregabalin
NCT00407745 A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury	Neuralgia, Spinal Cord Injuries	P3	Completed	220	RCT, Double-blind	placebo, pregabalin
NCT00219596 Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension	Glaucoma, Open Angle, Ocular Hypertension	P3	Completed	240	RCT, Open-label	Xalacom, unfixed Latanoprost and Timolol
NCT02459080 Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)	Chronic Obstructive Pulmonary Disease (COPD)	P3	Completed	619	RCT, Double-blind	TD-4208, Placebo
NCT00159861 The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH	Pulmonary Hypertension	P3	Completed	267	RCT, Double-blind	Sildenafil citrate
NCT02227862 Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)	Type 1 Diabetes	P3	Completed	558	RCT, Open-label	Mylan's insulin glargine, Lantus®
NCT00330785 Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia	Hypertension, Dyslipidemia	P3	Completed	1,250	Open-label	Amlodipine/Atorvastatin
NCT00551135 Surgical Pain After Inguinal Hernia Repair (SPAIHR)	Pain, Postoperative, Hernia, Inguinal	P3	Completed	425	RCT, Double-blind	Pregabalin, placebo, Pregabalin, Pregabalin
NCT00762463 Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis	Ankylosing Spondylitis	P3	Completed	240	RCT, Double-blind	Celecoxib, Diclofenac SR
NCT02245672 MGR001 / Advair Diskus Local Equivalence Study in Asthma	Asthma	P3	Completed	1,128	RCT, Double-blind	MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate), Advair (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate), Placebo
NCT00219544 Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.	Neuropathic Pain	P3	Completed	158	RCT, Double-blind	Pregabalin (Lyrica), Pregabalin (Lyrica), Pregabalin (Lyrica), Placebo
NCT01986270 Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo	Migraine With or Without Aura	P3	Completed	1,141	RCT, Double-blind	Placebo, Eletriptan 40 mg, Eletriptan 80 mg, Sumatriptan 25 mg, Sumatriptan 50 mg
NCT06525389 Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)	Talaromycosis	P3	Not Yet Recruiting	428	RCT, Double-blind	Liposomal Amphotericin B (LAmB), Flucytosine (5FC), Flucytosine (5FC) placebo pill, Deoxycholate Amphotericin B (DAmB)
NCT00141271 A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression	Bipolar Disorder	P3	Completed	536	RCT, Double-blind	Geodon (Ziprasidone), Geodon (Ziprasidone), Placebo
NCT00232141 Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy	HIV Infections, Peripheral Neuropathy	P3	Completed	302	RCT, Double-blind	pregabalin, Placebo
NCT01057693 Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy	Diabetic Neuropathy, Painful	P3	Completed	633	RCT, Double-blind	pregabalin (Lyrica), Placebo
NCT06215820 Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy	Acute Pain, Post Operative Pain	P3	Completed	410	RCT, Double-blind	MR-107A-02, Tramadol, Placebo
NCT01701362 Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain	Neuropathic Pain	P3	Completed	542	RCT, Double-blind	pregabalin, placebo
NCT00139737 Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia	Schizophrenia	P3	Completed	344	Open-label	Ziprasidone
NCT06400511 A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment	Blepharitis	P3	Terminated	477	RCT, Double-blind	Pimecrolimus 0.3% Ophthalmic Ointment, Placebo Ophthalmic Ointment
NCT00163046 A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance	Transient Insomnia	P3	Completed	256	RCT, Double-blind	Gabapentin, Placebo
NCT00312494 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects	Bipolar Disorder	P3	Completed	680	RCT, Double-blind	Placebo, Ziprasidone, Ziprasidone
NCT03095456 Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD	Chronic Obstructive Pulmonary Disease, COPD, Low Peak Inspiratory Flow Rate (PIFR)	P3	Completed	207	RCT, Double-blind	Revefenacin, Placebo for Revefenacin, Placebo for Spiriva Handihaler®
NCT01117220 Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)	Bipolar Disorder	P3	Withdrawn	—	RCT, Double-blind	Placebo, Ziprasidone Oral Capsules
NCT03376789 Mylan Insulin Glargine Study	Diabetes Mellitus, Type 1	P3	Completed	219	RCT, Double-blind	MYL-1501D product using manufacture process V, MYL-1501D product using manufacture process VI
NCT06349759 Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances	Mesopic Vision, Night Vision Loss	P3	Completed	200	RCT, Double-blind	phentolamine ophthalmic solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist, Placebo
NCT00830128 A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In Patients With Fibromyalgia	Fibromyalgia	P3	Completed	106	Open-label	pregabalin (Lyrica)
NCT00150280 Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery	Pain, Postoperative	P3	Completed	132	RCT, Double-blind	celecoxib and ibuprofen SR
NCT00827606 Atorvastatin Three Year Pediatric Study	Familial Hypercholesterolemia	P3	Completed	272	Open-label	atorvastatin
NCT03768726 Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder	Bipolar Disorder	P3	Terminated	23	Open-label	Ziprasidone, Placebo
NCT00645372 A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients	Schizophrenia	P3	Completed	242	RCT, Double-blind	Risperidone, Ziprasidone
NCT00468845 Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy	Pain, Postoperative	P3	Completed	501	RCT, Double-blind	pregabalin (Lyrica), pregabalin (Lyrica), matched placebo
NCT00977483 Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)	Diabetic Polyneuropathy	P3	Completed	460	RCT, Double-blind	Thioctic Acid, Placebo
NCT00751062 A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia	Open Angle Glaucoma, Ocular Hypertension	P3	Completed	267	RCT, Double-blind	timolol, PhXA41
NCT00280059 Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy	Epilepsy, Partial	P3	Completed	660	RCT, Double-blind	Pregabalin, Lamotrigine
NCT00644605 A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension	Hypertension, Pulmonary	P3	Completed	275	RCT, Double-blind	sildenafil, sildenafil, placebo, sildenafil
NCT01485887 Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)	Major Depressive Disorder	P3	Completed	50	Open-label	Venlafaxine ER
NCT00282464 A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.	Bipolar Disorder	P3	Completed	392	RCT, Double-blind	Placebo, Geodon (Ziprasidone)
NCT00666939 A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance	Transient Insomnia	P3	Completed	773	RCT, Double-blind	Gabapentin, Gabapentin, Placebo
NCT00645515 A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia	Schizophrenia	P3	Terminated	240	RCT, Double-blind	Ziprasidone, Risperidone
NCT00189241 A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma	Basal Cell Carcinoma	P3	Completed	160	Open-label	imiquimod
NCT00723606 A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation	Schizophrenia	P3	Completed	376	RCT, Open-label	Intramuscular ziprasidone mesylate, Intramuscular haloperidol
NCT00448916 Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures	Epilepsies, Partial	P3	Completed	54	Open-label	Pregabalin
NCT01271933 Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients	Fibromyalgia	P3	Completed	441	RCT, Double-blind	pregabalin, placebo
NCT01978496 Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine	Migraine With or Without Aura	P3	Completed	1,334	RCT, Double-blind	Placebo, Eletriptan 20 mg, Eletriptan 40 mg, Eletriptan 80 mg
NCT00147615 The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years	Hypertension	P3	Completed	140	Open-label	Eplerenone
NCT01049217 Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy	Neuropathy	P3	Terminated	377	RCT, Double-blind	pregabalin, placebo
NCT00553280 A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy	Diabetic Neuropathy, Painful	P3	Completed	123	Open-label	pregabalin
NCT00301223 A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain	Neuropathic Pain	P3	Completed	309	RCT, Double-blind	Pregabalin
NCT00141258 Pregabalin Epilepsy Add-On Trial	Partial Seizures	P3	Completed	178	RCT, Double-blind	pregabalin
NCT01145417 Pregabalin Trial In HIV Neuropathic Pain	HIV-1 Infection, Neuropathic Pain	P3	Terminated	217	Open-label	pregabalin (Lyrica)
NCT00151528 An Open-Label Trial of Pregabalin in Patients With Fibromyalgia	Fibromyalgia	P3	Completed	428	Open-label	Pregabalin
NCT01474772 Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)	Diabetic Peripheral Neuropathy	P3	Completed	217	RCT, Double-blind	Pregabalin
NCT00372528 An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures	Epilepsy	P3	Terminated	21	Open-label	pregabalin (LYRICA)
NCT00120523 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis	Atopic Dermatitis	P3	Completed	2,418	RCT, Open-label	Pimecrolimus, Topical corticosteroids
NCT03172780 A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee"	Osteoarthritis, Knee	P3	Completed	1,220	RCT, Double-blind	Diclofenac sodium gel 1%, Voltaren® Gel (Diclofenac Sodium Topical Gel) 1%, Placebo gel
NCT00163241 Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression	Osteoarthritis	P3	Terminated	666	RCT, Double-blind	celecoxib
NCT02666430 Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients	Type 1 Diabetes Mellitus	P3	Completed	127	RCT, Open-label	Mylan's insulin glargine, Lantus®
NCT01262677 Once-A-Day Pregabalin For Partial Seizures	Partial Seizures, Epilepsies, Partial	P3	Completed	325	RCT, Double-blind	pregabalin, pregabalin, pregabalin, pregabalin, pregabalin, pregabalin, placebo
NCT00553475 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy	Diabetic Neuropathy, Painful	P3	Completed	314	RCT, Double-blind	placebo, pregabalin, pregabalin
NCT00649844 A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs	Schizophrenia	P3	Completed	147	RCT, Double-blind	Clozapine, Ziprasidone
NCT02072824 A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.	Partial Onset Seizures	P3	Completed	175	RCT, Double-blind	Pregabalin Dose Level 1, Pregabalin Dose Level 2, Placebo
NCT00265382 Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia	Schizophrenia	P3	Terminated	221	Open-label	Ziprasidone oral capsules
NCT02195986 A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis	Atrophic Vaginitis	P3	Completed	366	RCT, Double-blind	Estradiol Vaginal Cream, 0.01%, Estrace® 0.01% cream, Placebo Vaginal Cream
NCT00136994 IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)	Schizophrenia	P3	Completed	160	Open-label	Ziprasidone
NCT01859481 Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study	Migraine Without Aura, Migraine With Aura	P3	Completed	971	RCT, Double-blind	Placebo, Eletriptan HBr 40 mg, Eletriptan HBr 80 mg
NCT00856622 A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients	Ocular Hypertension, Glaucoma	P3	Completed	436	RCT, Double-blind	i. Fixed combination of latanoprost 0.005% and timolol 0.5%, timolol 0.5% ophthalmic solution, latanoprost 0.005% ophthalmic solution
NCT00530946 A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin	Hypertension, Hypercholesterolemia	P3	Completed	165	RCT, Open-label	Amlodipine 2.5mg/Atorvastatin 5mg, Amlodipine 2.5mg/Atorvastatin 10mg, Amlodipine 5mg/Atorvastatin 5mg, Amlodipine 5mg/Atorvastatin 10mg
NCT00159770 Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients	Schizophrenia, Schizoaffective Disorder	P3	Completed	290	RCT, Open-label	ziprasidone versus olanzapine , risperidone or quetiapine
NCT00265330 Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)	Bipolar Disorder	P3	Completed	169	Open-label	Ziprasidone oral capsules
NCT01332149 Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy	Diabetic Neuropathy, Painful	P3	Completed	626	RCT, Double-blind	Pregabalin, Placebo matched with pregabalin
NCT00976716 An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain	Pain	P3	Completed	80	Open-label	Celecoxib
NCT00667108 A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance	Transient Insomnia	P3	Completed	784	RCT, Double-blind	Gabapentin, Gabapentin, Placebo
NCT01432236 A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression	Fibromyalgia	P3	Completed	197	RCT, Double-blind	Pregabalin, placebo
NCT00151489 Safety and Efficacy Study of Pregabalin in Fibromyalgia	Fibromyalgia	P3	Completed	1,020	RCT, Double-blind	pregabalin, placebo
NCT03610646 Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)	Diabetic Macular Edema	P3	Completed	355	RCT, Double-blind	MYL-1701P, Eylea
NCT02075047 Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder	Bipolar Disorder	P3	Terminated	171	RCT, Double-blind	placebo oral capsules, ziprasidone oral capsules
NCT00174447 Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031	Schizophrenia	P3	Completed	43	Open-label	Ziprasidone
NCT00230763 Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure	Glaucoma, Primary Open Angle (POAG), Ocular Hypertension	P3	Completed	396	Open-label	LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION
NCT00232180 A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines	Heart Failure	P3	Completed	2,743	Open-label	Eplerenone
NCT05139121 Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles	Contraception	P3	Completed	1,320	Open-label	MR-100A-01
NCT06475742 Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus	Lupus Erythematosus, Systemic	P3	By Invite	680	Open-label	Cenerimod
NCT02714322 MYL-1401A Efficacy and Safety Comparability Study to Humira®	Psoriasis, Arthritis, Psoriatic	P3	Completed	294	RCT, Double-blind	MYL-1401A (Adalimumab), Humira® (Adalimumab)
NCT01389596 A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years	Epilepsy, Partial Seizures	P3	Completed	295	RCT, Double-blind	Pregabalin add-on therapy, Pregabalin add-on therapy, Pregabalin add-on therapy
NCT00189280 Aldara for the Treatment of Large and/or Multiple sBCC	Carcinoma, Basal Cell	P3	Completed	111	Open-label	Imiquimod
NCT01115855 Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure	Heart Failure	P3	Completed	221	RCT, Double-blind	Eplerenone, Placebo
NCT01989936 Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan	Migraine With or Without Aura	P3	Completed	446	RCT, Double-blind	Placebo, Eletriptan 40 mg, Eletriptan 80 mg
NCT00549549 Celebrex In Acute Gouty Arthritis Study	Arthritis, Gouty	P3	Completed	402	RCT, Double-blind	Indomethacin, Celecoxib, Celecoxib, Celecoxib
NCT06215859 Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy	Acute Pain, Post Operative Pain	P3	Completed	579	RCT, Double-blind	MR-107A-02, Tramadol, Placebo
NCT00751049 A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom	Ocular Hypertension, Open Angle Glaucoma	P3	Completed	294	RCT, Double-blind	timolol, PhXA41
NCT03573817 A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD	Chronic Obstructive Pulmonary Disease (COPD)	P3	Completed	122	RCT, Double-blind	Revefenacin, Placebo, Formoterol
NCT01061372 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects	Restless Legs Syndrome	P3	Withdrawn	—	RCT, Double-blind	Placebo, pregabalin, pregabalin
NCT00159653 A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma	Glaucoma, Open-Angle, Ocular Hypertension	P3	Completed	500	RCT, Double-blind	Xalacom, Xalatan, Timolol
NCT00159913 A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.	Pulmonary Arterial Hypertension, Children	P3	Completed	235	RCT, Double-blind	Sildenafil citrate, Sildenafil citrate, Placebo, Sildenafil citrate
NCT00294320 Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions	Actinic Keratosis	P3	Completed	12	RCT, Double-blind	Aldara (Imiquimod)
NCT00141154 Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan	Low Back Pain	P3	Completed	1,234	RCT, Double-blind	Celecoxib, Placebo, Loxoprofen
NCT00346034 This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia	Fibromyalgia	P3	Completed	357	Open-label	Pregabalin
NCT03129321 Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis	Tinea Pedis	P3	Completed	876	RCT, Double-blind	Econazole Nitrate Cream, 1%, Placebo
NCT00368745 Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.	Generalized Anxiety Disorder	P3	Completed	108	RCT, Double-blind	Pregabalin, Placebo
NCT00442546 Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement	Osteoarthritis, Postoperative Pain	P3	Completed	307	RCT, Double-blind	pregabalin, pregabalin, Placebo
NCT00631943 A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain	Neuralgia	P3	Completed	112	Open-label	Pregabalin (Lyrica)
NCT00159874 A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children	Pulmonary Arterial Hypertension	P3	Completed	234	RCT, Open-label	Sildenafil citrate, Sildenafil citrate, Sildenafil citrate
NCT00883740 Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia	Fibromyalgia, Sleep Disorders	P3	Completed	119	RCT, Double-blind	Pregabalin, Placebo
NCT00343655 Evaluation of Atorvastatin Treatment on Carotid Plaque.	Cardiovascular Diseases	P3	Terminated	160	RCT, Double-blind	Atorvastatin
NCT01986088 Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study	Migraine With or Without Aura	P3	Completed	1,008	RCT, Double-blind	Placebo, Eletriptan 40 mg, Eletriptan 80 mg, Sumatriptan 50 mg, Sumatriptan 100 mg
NCT00143234 Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels	Hypertension, Hyperlipidemia	P3	Completed	1,825	Open-label	Amlodipine/atorvastatin single pill
NCT00394901 A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia	Neuralgia, Postherpetic	P3	Completed	372	RCT, Double-blind	Placebo, Pregabalin, Pregabalin, Pregabalin
NCT03384966 A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease	Stable Coronary Artery Disease	P2	Completed	346	RCT, Double-blind	Selatogrel, Placebo, Selatogrel
NCT01062113 Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain	Pain	P2	Completed	255	RCT, Double-blind	Celecoxib, Celecoxib, Placebo
NCT00777348 To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol	Asthma, Exercise-Induced	P2	Completed	62	RCT, Double-blind	Combination DSCG and Reproterol
NCT02109172 A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)	Chronic Obstructive Pulmonary Disease, COPD	P2	Completed	64	RCT, Double-blind	TD-4208, Placebo
NCT00636246 A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.	Depressive Disorder, Major	P2	Completed	510	RCT, Double-blind	sertraline/[S,S]-reboxetine, sertraline/[S,S]-reboxetine, sertraline, sertraline, sertraline/[S,S]-reboxetine, Placebo, sertraline/[S,S]-reboxetine, [S,S]-reboxetine monotherapy
NCT01704404 7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease	COPD	P2	Completed	62	RCT, Double-blind	TD-4208, Placebo
NCT01069861 Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)	PPHN, Persistent Pulmonary Hypertension of the Newborn	P2	Terminated	4	Open-label	sildanefil
NCT01379144 A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension	Primary Open Angle Glaucoma, Ocular Hypertension	P2	Completed	282	RCT, Double-blind	latanoprost 75 ug, latanoprost 100 ug, latanoprost 125 ug, latanoprost 50 ug
NCT00746967 An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder	Sexual Dysfunctions, Psychological, Sexual Arousal Disorder	P2	Completed	267	Open-label	sildenafil
NCT06126952 Azelastine Allergen Chamber - Onset of Action Study	Seasonal Allergic Rhinitis	P2	Completed	84	RCT, Double-blind	Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair), Treatment B: Placebo (Azelastine 0.15% vehicle) nasal spray, Treatment C: Ryaltris (Active Control) - mometasone furoate monohydrate and olopatadine hydrochloride nasal spray
NCT00143429 Corneal Versus Conjunctival Delivery Using a Delivery Device	Glaucoma, Open-Angle, Ocular Hypertension	P2	Withdrawn	—	RCT, Single-blind	Xalatan
NCT03742037 Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus	Systemic Lupus Erythematosus	P2	Completed	427	RCT, Double-blind	Cenerimod 0.5 mg, Cenerimod 1 mg, Cenerimod 2 mg, Cenerimod 4 mg, Placebo, cenerimod 2 mg (ex-4 mg)
NCT00640458 Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder	Female Sexual Arousal Disorder	P2	Completed	20	RCT, Double-blind	Sildenafil 100 mg, Placebo
NCT00189267 A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients	Actinic Keratosis	P2	Completed	45	RCT, Double-blind	Imiquimod 5 % Cream
NCT00437281 Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures	Epilepsies, Partial	P1P2	Completed	65	RCT, Double-blind	Placebo, Pregabalin
NCT05317312 Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.	Acute Pain, Post Operative Pain	P2	Completed	111	RCT, Double-blind	MR-107A-02, Placebo
NCT00915681 Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning	Amatoxin Poisoning, Amanita Poisoning	P2	Terminated	148	Open-label	Silibinin
NCT00650611 A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders	Schizophrenia, Bipolar Disorder	P2	Completed	63	RCT, Open-label	Ziprasidone, Ziprasidone
NCT00245609 Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure	Dental Anxiety	P2	Completed	90	RCT, Double-blind	Pregabalin, Alprazolam, Placebo
NCT00141310 Sildenafil Citrate for the Treatment of Established Pre-Eclampsia	Pre-eclampsia	P2	Terminated	76	RCT, Double-blind	Sildenafil citrate
NCT02040792 A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)	COPD	P2	Completed	355	RCT, Double-blind	TD-4208, Placebo
NCT01360671 IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn	Persistent Pulmonary Hypertension of the Newborn	P2	Withdrawn	—	Open-label	Sildenafil
NCT01018342 Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg	Healthy	P1	Completed	80	RCT, Open-label	Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg, Macrobid® Capsules 100 mg
NCT00649402 Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg	Healhty	P1	Completed	64	RCT, Open-label	Amlodipine and Benazepril HCl Capsules 10 mg/20 mg, Lotrel® Capsules 10 mg/20 mg
NCT01254396 Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.	Erectile Dysfunction	P1	Completed	12	RCT, Open-label	Sildenafil, Sildenafil
NCT00649597 Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg	Healthy	P1	Completed	56	RCT, Open-label	Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg, Lotensin HCT® Tablets 20 mg/25 mg
NCT00650520 Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets	Healthy	P1	Completed	119	RCT, Open-label	BROMOCRIPTINE MESYLATE CAPSULES, USP 5 mg, Parlodel® (bromocriptine mesylate) capsules, USP 5 mg
NCT00648856 Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg	Healthy	P1	Completed	21	RCT, Open-label	Sertraline Hydrochloride Tablets 100 mg, Zoloft® Tablets 100 mg
NCT00647881 Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg	Healthy	P1	Completed	75	RCT, Open-label	Paroxetine Hydrochloride Controlled-Release Tablets 25 mg, Paxil CR™ Tablets 25 mg
NCT01256151 Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet	Anxiety Disorder	P1	Completed	28	RCT, Open-label	Alprazolam tablet, Alprazolam sublingual
NCT00648713 Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg	Healthy	P1	Completed	36	RCT, Open-label	Terbinafine Hydrochloride Tablets 250 mg, Lamisil® Tablets 250 mg
NCT00987779 Bioequivalence Study Of Gabapentin Between Tablet And Liquid Formulation And The Food Effect Study Of Liquid Formulation	Healthy	P1	Completed	26	RCT, Open-label	Gabapentin, Gabapentin
NCT04819464 A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod	Healthy, Hepatic Impairment	P1	Completed	24	RCT, Open-label	Cenerimod
NCT03814200 A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects	Healthy Subject	P1	Completed	14	RCT, Double-blind	Saline, ACT-246475, Rifampicin
NCT00648921 Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg	Healthy	P1	Completed	30	RCT, Open-label	Olanzapine Tablets 5 mg, Zyprexa® Tablets 5 mg
NCT00647608 Food Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg	Healthy	P1	Completed	98	RCT, Open-label	Propranolol Hydrochloride Extended-Release Capsules 160 mg, Inderal® LA Capsules 160 mg
NCT00648544 Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects	Therapeutic Equivalency	P1	Completed	44	RCT, Open-label	Pravastatin, Pravastatin
NCT01046162 A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions	Healthy	P1	Withdrawn	—	RCT, Open-label	Alprazolam, Alprazolam
NCT01285505 Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation	Healthy	P1	Withdrawn	—	RCT, Open-label	alprazolam commercial sublingual formulation, alprazolam test sublingual tablet
NCT00800592 Sildenafil IV Bolus Study	Hypertension, Pulmonary	P1	Completed	12	Open-label	sildenafil
NCT01330472 An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites	Healthy Subjects	P1	Completed	16	RCT, Open-label	Xanax XR tablets 3 mg (sourced from Caugus), Xanax XR tablets 3 mg (sourced from Barceloneta)
NCT03173625 A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body	Healthy Subjects	P1	Completed	72	RCT, Double-blind	AC-076 for s.c. administration, Placebo
NCT00650208 Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg	Healthy	P1	Completed	27	RCT, Open-label	Lamotrigine Tablets 25 mg, Lamictal® Tablets 25 mg
NCT00648336 Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg	Healthy	P1	Completed	60	RCT, Open-label	Mercaptopurine 50 mg, Purinethol® Tablets 50 mg
NCT00648700 Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg	Healthy	P1	Completed	32	RCT, Open-label	Levothyroxine Sodium Tablets 300 μg, Levothroid® Tablets 300 μg
NCT02474017 An Open Study to Assess the Robustness of the CRC749 Inhaler	Asthma, COPD	P1	Completed	111	Open-label	MGR001
NCT00739999 8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia	Pediatric Heterozygous Hypercholesterolemia	P1	Completed	39	Open-label	Atorvastatin, Atorvastatin
NCT00648388 Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg	Healthy	P1	Completed	44	RCT, Open-label	Cilostazol Tablets 100 mg, Pletal® Tablets 100 mg
NCT00650403 Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg	Healthy	P1	Completed	66	RCT, Open-label	Paroxetine hydrochloride 40 mg tablet, Paxil® 40 mg Tablet
NCT01389609 Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition	Hypertension	P1	Completed	24	RCT, Open-label	Doxazosin 4 mg Japanese marketed IR tablet, Doxazosin 4 mg ODT with water, Doxazosin 4 mg ODT without water
NCT00649987 Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg	Healthy	P1	Completed	21	RCT, Open-label	Albuterol Sulfate Extended-Release Tablets 8 mg, VoSpire® ER Tablets 8 mg
NCT00925106 Pharmacokinetics Of Celecoxib Test Formulations	Healthy Volunteers	P1	Completed	16	RCT, Open-label	Celebrex capsule, Test formulation D1, Test formulation D2, Test formulation D3
NCT00638742 A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.	Glaucoma, Ocular Hypertension	P1	Completed	47	Open-label	latanoprost
NCT02215122 Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs	Asthma, COPD	P1	Completed	40	RCT, Open-label	MGR001, Advair® Diskus®, Seretide™ Accuhaler™
NCT00813241 A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers	Healthy Volunteers	P1	Completed	16	RCT, Open-label	celecoxib reference formulation, celecoxib test formulation A1, celecoxib test formulation B2, celecoxib test formulation C1
NCT02637193 A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects	Healthy Subjects	P1	Completed	54	RCT, Double-blind	Venlafaxine, Moxifloxacin, Drug - placebo
NCT00649519 Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg	Healthy	P1	Completed	54	RCT, Open-label	Amlodipine and Benazepril HCl Capsules 10 mg/20 mg, Lotrel® Capsules 10 mg/20 mg
NCT01235195 A Study Comparing the Drug Exposure in Humans After Administration of a 50 mg Tablet of Sertraline Hydrochloride as Compared to a 50 mg Capsule of Sertraline Hydrochloride Under Fasted (Nonfed) Conditions	Healthy	P1	Completed	30	RCT, Open-label	sertraline hydrochloride, sertraline hydrochloride
NCT00649974 Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg	Healthy	P1	Completed	28	RCT, Open-label	Valacyclovir Hydrochloride Tablets 1000 mg, Valtrex® Tablets 1000 mg
NCT00649103 Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg	Healthy	P1	Completed	60	RCT, Open-label	Quinapril Hydrochloride Tablets 40 mg, Accupril® Tablets 40 mg
NCT00647673 Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg	Healthy	P1	Completed	24	RCT, Open-label	Verapamil HCL Extended-Release Capsules 300 mg, Verelan® PM Extended-Release Capsules 300 mg
NCT01004614 Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet	Healthy	P1	Completed	48	RCT, Open-label	Amlodipine, Amlodipine, Amlodipine, Amlodipine
NCT00650325 Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg	Healthy	P1	Completed	49	RCT, Open-label	Sertraline Hydrochloride Tablets 100 mg, Zoloft® Tablets 100 mg
NCT01027117 A Relative Bioavailability Study of Revatio for the Crushed Tablets, Extemporaneously Prepared Formulation, and the Intact Tablets at 20 mg Dose in Healthy Volunteers	Healthy	P1	Completed	18	RCT, Open-label	Revatio, Revatio, Revatio
NCT00647816 Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg	Healthy	P1	Completed	100	RCT, Open-label	Propranolol Hydrochloride Extended-Release Capsules 160 mg, Inderal® LA Capsules 160 mg
NCT00990223 Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity	Healthy Volunteers	P1	Completed	20	RCT, Double-blind	Eplerenone or Placebo
NCT00647959 Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg	Healthy	P1	Completed	36	RCT, Open-label	Doxycycline Tablets, 150mg, Adoxa Tablets 150 mg
NCT01737203 Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil	Healthy	P1	Completed	53	RCT, Open-label	Viagra, sildenafil ODT, sildenafil ODT
NCT00649350 Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg	Healthy	P1	Completed	28	RCT, Open-label	Metformin Hydrochloride ER Tablets 750 mg, Glucophage XR 750 mg
NCT00650221 Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects	Therapeutic Equivalency	P1	Completed	43	RCT, Open-label	Pravastatin, Pravastatin
NCT00649532 Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg	Healthy	P1	Completed	28	RCT, Open-label	Ondansetron Tablets 24 mg, Zofran® Tablets 24 mg
NCT00647660 Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg	Healthy	P1	Completed	66	RCT, Open-label	Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg, Corzide® Tablets 80 mg/5 mg
NCT00649259 Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg	Healthy	P1	Completed	39	RCT, Open-label	Oxybutynin Chloride ER Tablets 10 mg, Ditropan XL® Tablets 10 mg
NCT06273254 A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions	Bioequivalence Study	P1	Unknown	48	RCT, Open-label	Sacubitril and Valsartan Tablets 49mg/51mg, Entresto® (Sacubitril and Valsartan Tablets 49mg/51mg)
NCT00648011 Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg	Healthy	P1	Completed	44	RCT, Open-label	Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg, Accuretic™ Tablets 20 mg/25 mg
NCT00649805 Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg	Healthy	P1	Completed	24	RCT, Open-label	Verapamil Hydrochloride Extended-Release Capsules, 300 mg, Verelan® PM Extended-Release Capsules, 300 mg
NCT02772159 TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects	Chronic Obstructive Pulmonary Disease (COPD)	P1	Completed	9	Open-label	TD-4208
NCT00950404 Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet	Healthy Volunteers	P1	Completed	16	RCT, Open-label	Viagra 50 mg tablet, Formulation B ODT tablet 50 mg, Formulation C ODT tablet 50 mg, Formulation D ODT tablet 50 mg
NCT01019590 Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg	Healthy	P1	Completed	36	RCT, Open-label	Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg, Benicar HCT ® Tablets 40 mg/25 mg
NCT01443169 A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted	Healthy	P1	Completed	16	RCT, Open-label	Sequence 1 - Treatment A: Controlled Release Pregabalin, Sequence 1 - Treatment B: Controlled Release Pregabalin, Sequence 1 - Treatment C:Controlled Release Pregabalin, Sequence 1 - Treatment D: Controlled Release Pregabalin, Sequence 1 - Treatment E: Immediate Release Pregabalin, Sequence 2 - Treatment B: Controlled Release Pregabalin, Sequence 2 - Treatment D: Controlled Release Pregabalin, Sequence 2 - Treatment A: Controlled Release Pregabalin, Sequence 2 - Treatment C: Controlled Release Pregabalin, Sequence 2 - Treatment E: Immediate Release Pregabalin, Sequence 3 - Treatment C: Controlled Release Pregabalin, Sequence 3 - Treatment A: Controlled Release Pregabalin, Sequence 3 - Treatment D: Controlled Release Pregabalin, Sequence 3 - Treatment B: Controlled Release Pregabalin, Sequence 3 - Treatment E: Immediate Release Pregabalin, Sequence 4 - Treatment D: Controlled Release Pregabalin, Sequence 4 - Treatment C: Controlled Release Pregabalin, Sequence 4 - Treatment B: Controlled Release Pregabalin, Sequence 4 - Treatment A: Controlled Release Pregabalin, Sequence 4 - Treatment E: Immediate Release Pregabalin
NCT00649636 Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg	Healthy	P1	Completed	32	RCT, Open-label	Fluoxetine Capsules 40 mg, Prozac Pulvules 40 mg
NCT00648271 Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg	Healthy	P1	Completed	19	RCT, Open-label	Metoprolol Tartrate Tablets 25 mg, Lopressor® Tablets 50 mg
NCT00649363 Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg	Healthy	P1	Completed	28	RCT, Open-label	Ondansetron Orally Disintegrating Tablets 8 mg, Zofran ODT® Tablets 8 mg
NCT00649714 Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg	Healthy	P1	Completed	110	RCT, Open-label	Zonisamide Capsules 100 mg, Zonegran® Capsules 100 mg
NCT00648830 Comparative Bioavailability Study of Clarithromycin 250 mg Tablets	Healthy	P1	Completed	32	RCT, Open-label	Clarithromycin
NCT00648505 Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg	Healthy	P1	Completed	36	RCT, Open-label	Glipizide and Metformin HCl Tablets 5 mg/500 mg, Metaglip® Tablets 5 mg/500 mg
NCT00649675 Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg	Healthy	P1	Completed	27	RCT, Open-label	Meloxicam Tablets 15 mg, Mobic® Tablets 15 mg
NCT00649272 Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mg	Healthy	P1	Completed	80	RCT, Open-label	Oxybutynin Chloride Extended-Release Tablets, 15 mg, Ditropan XL® Extended-release tablets, 15 mg
NCT07301723 A Trial to Evaluate the Absolute Bioavailability of Cenerimod in Healthy Male Participants	Healthy Subjects	P1	Completed	6	Open-label	Cenerimod (oral), 14C-Cenerimod (i.v.)
NCT01291524 Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers	Healthy	P1	Completed	24	RCT, Open-label	Pregabalin controlled release, 330 mg, 400 to 500 calorie, Pregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg, bedtime, Pregabalin immediate release, 300 mg
NCT00648934 Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg	Healthy	P1	Completed	36	RCT, Open-label	Topiramate Sprinkle Capsules 25 mg, Topamax® Sprinkle Capsules 25 mg
NCT00647634 Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg	Healthy	P1	Completed	21	RCT, Open-label	Alprazolam Extended-Release Tablets 3 mg, Xanax XR® Tablets (3 mg
NCT01342198 An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet	Healthy	P1	Completed	18	RCT, Open-label	Pregabalin controlled release, 330 mg, Pregabalin controlled release, 330 mg, erythromycin
NCT04391868 A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form	Healthy	P1	Withdrawn	—	RCT, Open-label	Viagra Tablet, Sildenafil Citrate ODF, Sildenafil Citrate ODF
NCT00648661 Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg	Healthy	P1	Completed	35	RCT, Open-label	Escitalopram Oxalate Tablets 20 mg, Lexapro® Tablets 20 mg
NCT00649233 Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg	Healthy	P1	Completed	32	RCT, Open-label	Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg, Lopressor HCT® Tablets 100/50 mg
NCT01177293 Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules	Healthy Volunteers	P1	Completed	14	RCT, Open-label	Amlodipine - reference, Amlodipine ODT - test
NCT00649155 Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg	Healthy	P1	Completed	36	RCT, Open-label	Ciprofloxacin Extended-Release Tablets 500 mg, Cipro® XR Tablets (500 mg
NCT00649181 Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg	Healthy	P1	Completed	52	RCT, Open-label	Metolazone Tablets 5 mg, Zaroloxyn® Tablets 5 mg
NCT04557280 A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects	Healthy Subjects	P1	Completed	24	RCT, Open-label	Selatogrel
NCT00649441 Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg	Healthy	P1	Completed	60	RCT, Open-label	Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg, Accuretic™ Tablets 20 mg/25 mg
NCT03430661 A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects	Healthy	P1	Completed	77	RCT, Double-blind	ACT-246475, Clopidogrel, Prasugrel, Placebo, Ticagrelor
NCT00649870 Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg	Healthy	P1	Completed	26	RCT, Open-label	Valacyclovir Hydrochloride Tablets 1000 mg, Valtrex® Tablets 1000 mg
NCT00649662 Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg	Healthy	P1	Completed	36	RCT, Open-label	Ciprofloxacin Extended-Release Tablets 1000 mg, Cipro® XR Tablets 1000 mg
NCT00760474 An fMRI Study Of Brain Response In Patients With Fibromyalgia	Fibromyalgia	P1	Completed	27	RCT, Double-blind	Pregabalin, then placebo, Placebo, then pregabalin
NCT00648791 Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg	Healthy	P1	Completed	29	RCT, Open-label	Finasteride Tablets 5 mg, Proscar Tablets 5 mg
NCT02578082 Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment	Renal Impairment	P1	Completed	16	Open-label	TD-4208
NCT00650117 Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System	Healthy	P1	Completed	12	RCT, Open-label	Mylan Fentanyl Transdermal System 25 mcg/h + Scotch Duct Tape (3M), Duragesic 25 mcg/h + Scotch Duct Tape (3M), Mylan Fentanyl Transdermal System 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M), Duragesic 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M), Mylan Fentanyl Transdermal System 25 mcg/h + Microfoam Tape (3M), Duragesic 25 mcg/h + Microfoam Tape (3M)
NCT01355068 A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia	Healthy	P1	Completed	26	RCT, Open-label	Epanutin Infatabs (Phenytoin), Dilantin Infatabs (Phenytoin)
NCT00647738 Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State	Healthy	P1	Completed	27	RCT, Open-label	Baclofen, Baclofen
NCT02472912 Adalimumab PK Bioequivalence Study to EU and US Sourced Humira	Healthy Volunteers	P1	Completed	270	RCT, Double-blind	BMO-2, EU-Humira, US-Humira
NCT00758004 Bioequivalence Study Of Pediatric Appropriate Formulation	Hypercholesterolemia	P1	Completed	76	RCT, Open-label	Atorvastatin, Atorvastatin pediatric appropriate formulation
NCT00649285 Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg	Healthy	P1	Completed	71	RCT, Open-label	Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg, Macrobid® Capsules 100 mg
NCT00877955 Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation	Healthy	P1	Withdrawn	—	RCT, Open-label	alprazolam sublingual tablet commercial, alprazolam sublingual tablet test
NCT00866463 A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects	Erectile Dysfunction	P1	Completed	18	RCT, Open-label	Sildenafil, Sildenafil, Sildenafil
NCT00650000 Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg	Healthy	P1	Completed	32	RCT, Open-label	Modafinil Tablets 200 mg, Provigil® Tablets 200 mg
NCT00821444 Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules	Healthy	P1	Completed	11	RCT, Open-label	ziprasidone, B16 Fasted, B16 Fed
NCT00795938 Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects.	Erectile Dysfunction	P1	Completed	18	RCT, Open-label	Sildenafil, Sildenafil, Sildenafil
NCT00650013 Fed Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg	Healthy	P1	Completed	23	RCT, Open-label	Midodrine HCl Tablets 5 mg, ProAmatine® Tablets 5 mg
NCT00650364 Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg	Healthy	P1	Completed	38	RCT, Open-label	Midodrine HCl Tablets 5 mg, ProAmatine® Tablets 5 mg
NCT01202422 An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule	Healthy	P1	Completed	24	RCT, Open-label	Pregabalin controlled release, 165 mg, Pregabalin controlled release, 330 mg, Pregabalin immediate release, 150 mg
NCT00650286 Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg	Healthy	P1	Completed	20	RCT, Open-label	Modafinil Tablets 200 mg, Provigil® Tablets 200 mg
NCT04255277 To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.	Healthy Subjects	P1	Completed	97	RCT, Double-blind	Combined oral contraceptives (COC), Moxifloxacin 400mg, Cenerimod 0.5 mg, Cenerimod 4 mg, Matching Placebo
NCT02479646 Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta	Healthy Volunteers	P1	Completed	218	RCT, Double-blind	MYL-1401H, EU-Neulasta, US-Neulasta
NCT00649454 Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg	Healthy	P1	Completed	36	RCT, Open-label	Glipizide and Metformin HCl Tablets 5 mg/500 mg, Metaglip® Tablets 5 mg/500 mg
NCT02820311 Thorough QT (TQT) Study of TD-4208 in Healthy Subjects	Cardiac Repolarization in Healthy Subjects	P1	Completed	48	RCT, Double-blind	TD-4208 175 mcg, TD-4208 700 mcg, Placebo for TD-4208, Moxifloxacin 400 mg
NCT00647894 Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg	Healthy	P1	Completed	24	RCT, Open-label	Alprazolam Extended-Release Tablets 1 mg, Xanax XR Tablets 1 mg
NCT00648843 Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg	Healthy	P1	Completed	28	RCT, Open-label	Oxybutynin Chloride Extended-release Tablets 5 mg, Ditropan XL® Tablets 5 mg
NCT00648180 Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg	Healthy	P1	Completed	36	RCT, Open-label	Doxycycline Monohydrate Tablets 100 mg, Adoxa Tablets 100 mg
NCT00650533 Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg	Healthy	P1	Completed	40	RCT, Open-label	Glimepiride Tablets 1 mg, Amaryl® Tablets 1 mg
NCT00650481 Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg	Healthy	P1	Completed	60	RCT, Open-label	Oxybutynin Chloride Extended-release Tablets 5 mg, Ditropan XL® Tablets 5 mg
NCT01257529 An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers	Healthy	P1	Completed	28	RCT, Open-label	Pregabalin controlled release, 330 mg, low-fat, Pregabalin controlled release, 330 mg, medium-fat, Pregabalin controlled release, 330 mg, high-fat, Pregabalin immediate release, 300 mg
NCT04176367 An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants	Pharmacokinetics	P1	Completed	40	RCT, Open-label	Nicergoline from China, Nicergoline from Italy
NCT07615868 A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Chinese Adults With Chronic Coronary Syndrome	Chronic Coronary Syndrome	P1	Completed	20	RCT, Double-blind	—
NCT00650416 Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg	Healthy	P1	Completed	50	RCT, Open-label	Carvedilol Tablets 12.5 mg, Coreg® Tablets 12.5 mg
NCT00481728 Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.	Overactive Bladder	P1	Completed	28	RCT, Double-blind	Tolterodine
NCT00650169 Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg	Healthy	P1	Completed	47	RCT, Open-label	Clopidogrel Bisulfate Tablets 75 mg, Plavix® Tablets 75 mg
NCT00649740 Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg	Healthy	P1	Completed	36	RCT, Open-label	Topiramate Sprinkle Capsules 25 mg, Topamax® Sprinkle Capsule 25 mg
NCT04406896 The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics	Healthy Subjects, Hepatic Impairment	P1	Completed	24	Open-label	Selatogrel
NCT00648518 Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mg	Healthy	P1	Completed	36	RCT, Open-label	Metformin Hydrochloride ER Tablets 750 mg, Glucophage® XR Tablets 750 mg
NCT02651623 Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects	Healthy	P1	Completed	54	RCT, Double-blind	Sertraline, Moxifloxacin, Drug - Placebo
NCT00650195 Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg	Healthy	P1	Completed	56	RCT, Open-label	Metolazone Tablets 10 mg, Zaroloxyn® Tablets 10 mg
NCT00860119 Bioequivalence of Alprazolam Sublingual vs Oral Tablets	Healthy	P1	Completed	23	RCT, Open-label	alprazolam sublingual tablet, alprazolam oral tablet
NCT02469987 Phase I - Pharmacokinetic Comparability Study in Healthy Male Volunteers	Healthy	P1	Completed	111	RCT, Double-blind	MYL-1402O, US marketed Avastin(R), EU marketed Avastin(R)
NCT00649467 Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg	Healthy	P1	Completed	35	RCT, Open-label	Topiramate Sprinkle Capsules 25 mg, Topamax® Sprinkle Capsules 25 mg
NCT04052360 Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects	Healthy Volunteers	P1	Completed	20	RCT, Double-blind	Cenerimod, Matching Placebo
NCT00649038 Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg	Healthy	P1	Completed	24	RCT, Open-label	Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg, Lotensin HCT® Tablets 20 mg/25 mg
NCT00904748 A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate	Erectile Dysfunction	P1	Completed	47	RCT, Open-label	sildenafil citrate 100 mg CT, sildenafil citrate 100 mg CT, Viagra®
NCT00777517 Bioequivalence Study On Pediatric Appropriate Formulation	Hypercholesterolemia	P1	Completed	76	RCT, Open-label	Lipitor, Atorvastatin pediatric formulation
NCT00649168 Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg	Healthy	P1	Completed	120	RCT, Open-label	BROMOCRIPTINE MESYLATE CAPSULES, USP 5 mg, Parlodel® (bromocriptine mesylate) capsules, USP 5 mg
NCT00649857 Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg	Healthy	P1	Completed	18	RCT, Open-label	Cetirizine HCl Tablets 10 mg, Zyrtec® 10 mg
NCT00649116 Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg	Healthy	P1	Completed	20	RCT, Open-label	Metoprolol Tartrate Tablets 100 mg, Lopressor® Tablets 100 mg
NCT00648531 Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg	Healthy	P1	Completed	80	RCT, Open-label	Balsalazide Disodium Capsules 750 mg, Colazal® Capsules 750 mg
NCT00647972 Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg	Healthy	P1	Terminated	32	RCT, Open-label	Olanzapine Tablets 20 mg, Zyprexa® Tablets 20 mg
NCT00649571 Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg	Healthy	P1	Completed	35	RCT, Open-label	Doxycycline Monohydrate Tablets (100 mg, Adoxa Tablets 100 mg
NCT00649493 Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg	Healthy	P1	Completed	72	RCT, Open-label	Rabeprazole Sodium Tablets 20 mg, Aciphex® Tablets 20 mg
NCT00649558 Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg	Healthy	P1	Completed	36	RCT, Open-label	Pioglitazone HCl Tablets 45 mg, Actos® Tablets 45 mg
NCT00871806 Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water	Healthy Volunteers	P1	Completed	20	RCT, Open-label	Commercial tablet with water, ODT #1 without water, ODT #2 without water, ODT #1 with water, ODT #2 with water
NCT00648219 Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg	Healthy	P1	Completed	36	RCT, Open-label	Olmesartan Medoxomil Tablets 40 mg, Benicar® Tablets 40 mg
NCT02725112 Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers	Healthy	P1	Completed	25	RCT, Open-label	Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER
NCT00649623 Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg	Healthy	P1	Completed	36	RCT, Open-label	Olmesartan Medoxomil Tablets 40 mg, Benicar® Tablets 40 mg
NCT00649727 Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mg	Healthy	P1	Completed	24	RCT, Open-label	Oxybutynin Chloride ER Tablets 10 mg, Ditropan XL® Tablets 10 mg
NCT00649948 Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg	Healthy	P1	Completed	27	RCT, Open-label	Metformin Hydrochloride ER Tablets 500 mg, Glucophage XR 500 mg
NCT00649818 Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg	Healthy	P1	Completed	28	RCT, Open-label	Lorazepam Tablets 2 mg, Ativan Tablets 2 mg
NCT02914223 A Study to Evaluate Cenerimod in Healthy Male Subjects	Healthy Subjects	P1	Completed	6	Open-label	Cenerimod
NCT00648050 Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mg	Healthy	P1	Completed	72	RCT, Open-label	Verapamil Hydrochloride Extended-Release Capsules, 300 mg, Verelan® PM Extended-Release Capsules, 300 mg
NCT00647686 Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay	Healthy	P1	Completed	80	RCT, Open-label	Fentanyl Transdermal System 25 mcg/h + Askina Derm Overlay, Fentanyl Transdermal System 25 mcg/h
NCT00650494 Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg	Healthy	P1	Completed	66	RCT, Open-label	Valacyclovir Hydrochloride Tablets 1000mg, Valtrex® 1000 mg
NCT00649129 Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg	Healthy	P1	Completed	36	RCT, Open-label	Oxybutynin Chloride ER Tablets 10 mg, Ditropan XL® Tablets 10 mg
NCT06266988 A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions	Chronic Heart Failure	P1	Unknown	48	RCT, Open-label	Sacubitril and Valsartan Tablets 97mg/103mg, Entresto (Sacubitril and Valsartan Tablets 97mg/103mg)
NCT00648349 Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg	Healthy	P1	Completed	72	RCT, Open-label	Rabeprazole Sodium Delayed-Release Tablets 20 mg, Aciphex® Delayed-Release Tablets 20 mg
NCT00649506 Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mg	Healthy	P1	Completed	28	RCT, Open-label	Nitrofurantoin Macrocrystals 100 mg Capsules, Macrodantin® 100 mg Capsules
NCT01257516 An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers	Healthy	P1	Completed	18	RCT, Open-label	Pregabalin immediate release, 300 mg, Pregabalin controlled release, 330 mg
NCT00648414 Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr	Healthy	P1	Terminated	12	RCT, Open-label	Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 1, Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 2, Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 3, Duragesic 25 mcg/h + Clinical Procedure 1, Duragesic 25 mcg/h + Clinical Procedure 2, Duragesic 25 mcg/h + Clinical Procedure 3
NCT01656798 Food Effect Study For New Formulation	Healthy	P1	Completed	12	RCT, Open-label	sildenafil citrate, sildenafil citrate
NCT01020214 Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg	Healthy	P1	Completed	36	RCT, Open-label	Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg, Benicar HCT® Tablets 40 mg/25 mg
NCT00648297 Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg	Healthy	P1	Completed	42	RCT, Open-label	Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg, Corzide® Tablets 80 mg/5 mg
NCT00649480 Fed Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg	Healthy	P1	Completed	60	RCT, Open-label	BALSALAZIDE DISODIUM CAPSULES, 750 MG, COLAZAL® Capsules 750 mg
NCT01247805 A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions	Pulmonary Arterial Hypertention	P1	Completed	42	RCT, Open-label	sildenafil citrate, Sildenafil citrate, sildenafil citrate
NCT01027689 Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation	Healthy	P1	Withdrawn	—	RCT, Open-label	alprazolam commercial immediate release oral tablet, alprazolam test sublingual tablet
NCT01521767 Pharmacokinetics and Relative Bioavailability Study	Urinary Bladder, Overactive	P1	Completed	16	RCT, Open-label	tolterodine tartrate, tolterodine tartrate, tolterodine tartrate, tolterodine tartrate, tolterodine tartrate
NCT05207111 Fasting Bioavailability Study of Mylan's Revefenacin Inhalation Solution	Healthy Volunteers Bioavailability Study	P1	Completed	24	Open-label	Revefenacin Inhalation Solution
NCT00650273 Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg	Healthy	P1	Completed	54	RCT, Open-label	Azithromycin Tablets 600 mg, Zithromax® Tablets 600 mg
NCT01270815 An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers	Healthy	P1	Completed	28	RCT, Open-label	Pregabalin controlled release, 330 mg, 400 to 500 calories, Pregabalin controlled release, 330 mg, 600 to 750 calories, Pregabalin controlled release, 330 mg, 800 to 1000 calories, Pregabalin immediate release, 300 mg
NCT00649935 Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg	Healthy	P1	Completed	54	RCT, Open-label	Azithromycin Tablets 600 mg, Zithromax® Tablets 600 mg
NCT00648583 Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg	Healthy	P1	Completed	28	RCT, Open-label	Ondansetron Tablets 24 mg, Zofran® Tablets 24 mg
NCT00650351 Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg	Healthy	P1	Completed	35	RCT, Open-label	Ciprofloxacin Extended-Release Tablets 1000 mg, Cipro® XR Tablets 1000 mg
NCT01190852 Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays	Allergic Rhinitis	P1	Completed	30	RCT, Open-label	Azelastine, Fluticasone, Azelastine mono, Azelastine
NCT01321671 Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers	Healthy	P1	Completed	24	RCT, Open-label	Pregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg, fasted, Pregabalin immediate release, 300 mg
NCT00579254 Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors	Hypertension and Cardiovascular Risk Factors		Terminated	112	—	CADUET (AMLODIPINE 5 mg/ATORVASTATIN 10 mg or 20 mg)
NCT05544695 Real-world Evidence Study on Cystistat	Interstitial Cystitis and Bladder Pain Syndrome		Completed	74	—	—
NCT02958527 Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)	Depression/Depressed State		Completed	1,408	—	venlafaxine
NCT01427712 Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis	Cystic Fibrosis, Exocrine Pancreatic Insufficiency		Completed	24	—	Pancrelipase
NCT00541476 Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica	Neuralgia		Completed	746	—	—
NCT05546125 a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China	Pulmonary Arterial Hypertension (PAH)		Completed	100	—	—
NCT01632878 Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study	Myocardial Infarction (MI)		Completed	1,531	—	—
NCT00674687 A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing	Neuralgia, Neuralgia, Postherpetic	N/A	Completed	23	RCT, Double-blind	2-weeks placebo then gabapentin, 1-week placebo then gabapentin
NCT01243138 Africa and Middle East Cardiovascular Epidemiological Study	Obesity, Smoking		Completed	4,386	—	—
NCT00878943 Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study	Pulmonary Arterial Hypertension		NO_LONGER_AVAILABLE	—	—	Sildenafil citrate
NCT01280747 Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study	Fibromyalgia, Painful Diabetic Peripheral Neuropathy		Terminated	42	—	—
NCT01773993 Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)	Pain Associated With Fibromyalgia		Completed	534	—	Pregabalin
NCT01441401 Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan)	Epilepsies, Partial		Completed	82	—	gabapentin
NCT01582438 An Open Label Access Study For Subjects Who Completed A1481156	Pulmonary Arterial Hypertension		NO_LONGER_AVAILABLE	—	—	Access program - sildenafil citrate, Viagra, Revatio
NCT00759174 A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION	Optic Neuropathy, Ischemic		Completed	673	—	No intervention
NCT05030025 Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg)	HIV-1-infection	Early P1	Completed	43	RCT, Open-label	—
NCT01220180 Lyrica (Pregabalin) Korean Post Marketing Surveillance Study	Epilepsy, Neuropathic Pain		Completed	4,175	—	pregabalin (Lyrica), pregabalin (Lyrica), pregabalin (Lyrica)
NCT00946114 To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks	Pulmonary Hypertension		Completed	32	—	sildenafil, sildenafil
NCT00486252 Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®	Glaucoma,Open-Angle, Ocular Hypertension		Completed	996	—	—
NCT03342690 Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)	Chronic Heart Failure		Completed	1,165	—	Eplerenone
NCT00599768 Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.	Neuralgia, Nerve Pain		Completed	325	—	—
NCT01801982 A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)	Pulmonary Hypertension, Persistent, of the Newborn		Completed	1	—	—
NCT01256593 Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)	Neuralgia		Completed	3,827	—	Pregabalin (Lyrica) capsule
NCT02273908 PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin	Low-Back Pain		Completed	331	—	—
NCT01206361 Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom	Glaucoma, Ocular Hypertension		Completed	2,015	—	XALACOM, Duotrav, Ganfort
NCT00892008 A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin	Neuropathic Pain		Completed	2,278	—	Pregabalin
NCT00801437 Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.	Glaucoma, Open-angle		Completed	457	—	Xalacom
NCT00584519 Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight	Schizophrenia		Completed	430	—	—
NCT01279850 Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)	Neuropathic Pain		Completed	891	—	Pregabalin (Lyrica) capsule
NCT01792622 Patient Reported Outcomes in Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension		Withdrawn	—	—	—
NCT02868359 PROs in Chronic Cervical Pain Patients With Accompanying Upper Limb Radiating Pain Treated With Pregabalin	Cervical Pain, Neuropathic Pain		Completed	369	—	—
NCT01078285 Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor	Medication Non-Adherence		Completed	500	—	—
NCT01427725 Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency	Exocrine Pancreatic Insufficiency, Pancreatic Diseases		Completed	579	—	Lipacreon
NCT02322710 Comparison of Efficacy on Healing, and Safety of Two Dressings Urgotul and TulleGras MS on Surgical Acute Wounds.	Surgical Acute Wounds	N/A	Completed	208	RCT, Single-blind	—
NCT02579122 REVIparin-BRIDging-in a General Practice Setting in GErmany	Thromboembolism		Terminated	77	—	—
NCT00828945 Compliance With Treatment For Patients With Hyperlipidemia	Hyperlipidemia		Completed	259	—	—
NCT02104180 Evaluation of Pain Associated With the Removal of Wound Dressing During Care of Venous Leg Ulcer. Comparison of the Efficacy and Safety of Two Dressings Urgotul and TulleGras	Venous Leg Ulcer	N/A	Completed	62	RCT, Open-label	—
NCT00922987 Clinical Study With Lyrica In Patients Suffering From Epilepsy	Neuralgia, Epilepsy		Completed	286	—	Lyrica (pregabalin)
NCT00334750 Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada	Glaucoma, Open-Angle, Ocular Hypertension		Completed	410	—	—
NCT01191008 Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension	Glaucoma, Ocular Hypertension		Completed	661	—	Latanoprost-timolol maleate fixed combination ophthalmic solution
NCT00866983 Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil	Pulmonary Arterial Hypertension		NO_LONGER_AVAILABLE	—	—	sildenafil (Revatio) 20 mg TID
NCT00978341 Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design	Spinal Cord Injuries	N/A	Terminated	15	RCT, Double-blind	Pregabalin, Placebo for pregabalin
NCT05051527 Study to Evaluate the Effectiveness of Legalon®	Non-alcoholic Fatty Liver Disease (NAFLD)		Completed	362	—	Legalon® 140 mg
NCT01607593 A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients	Posttraumatic Stress Disorder		Completed	123	—	sertraline (Zoloft)
NCT01897740 Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil	Pulmonary Arterial Hypertension		NO_LONGER_AVAILABLE	—	—	sildenafil
NCT04976868 Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis	Atopic Dermatitis		Completed	130	—	Pimecrolimus 1% Top Cream
NCT00709787 Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management	Hypertension		Completed	899	—	—
NCT00649324 Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mg	Healthy	Early P1	Completed	40	RCT, Open-label	Hydrochlorothiazide Tablets 50 mg, Hydrochlorothiazide Tablets (50 mg
NCT00605813 Special Investigation Of Long Term Use Of Sertraline.	Depression, Panic Disorder		Completed	542	—	Sertraline hydrochloride
NCT02449031 Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs	Pseudomonas Aeruginosa in Cystic Fibrosis		Completed	409	—	TOBI® PODHALER®, TOBI®, Bethkis®, Cayston®
NCT05000541 Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical	Hypercholesterolemia		Completed	259	—	—
NCT00666198 Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)	Pulmonary Hypertension		Completed	3,337	—	SILDENAFIL
NCT00579670 Treatment of Schizophrenic Patients With Ziprasidone	Schizophrenia		Completed	450	—	Ziprasidone
NCT01053429 A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule	Bipolar Disorder, Schizophrenia		Completed	3,391	—	ziprasidone
NCT00768573 Taste Test of a New Formulation of Sildenafil (Revatio)	None Volunteer		Completed	4	—	sildenafil
NCT01150903 Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor	Erectile Dysfunction, Cardiovascular Diseases		Completed	98,832	—	—
NCT00567268 Drug Use Investigation Of Gabapentin	Epilepsies, Partial		Completed	1,273	—	Gabapentin
NCT05158972 Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients	Allergic Rhinitis		Completed	924	—	Dymista